HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation
SCIE
SCOPUS
- Title
- HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation
- Authors
- Cho, JW; Baek, WK; Yang, SH; Chang, J; Sung, YC; Suh, MH
- Date Issued
- 2001-02-05
- Publisher
- ELSEVIER SCIENCE BV
- Abstract
- It has been recognized that the HCV (hepatitis C virus) core protein plays an important role in hepatocarcinogenesis. The functional inactivation of the Rb pathway appears to be a major event for multi-step cancer carcinogenesis. To elucidate the role of the HCV core protein in hepatocarcinogenesis, we investigated the effect of the HCV core protein on the Rb pathway in both Rat-1 cell lines, stably expressing the HCV core protein and the doxycycline-regulated cell lines. The HCV core stable transfectants showed a dramatic decrease ill the pRb levels and E2F-1 up-regulation. In the doxycycline-regulated cell lines, the PRb levels were significantly decreased which are followed by E2F-1 up-regulation. HCV core stable transfectants showed higher cell growth rates and were sensitize to apoptosis. Thus, our results first indicate that the HCV core protein decreases the expression of pRb, thereby allowing E2F-1 to be constitutively active, which is thought to result in rapid cell proliferation or sensitizing to apoptosis. (C) 2001 Elsevier Science B.V. All rights reserved.
- Keywords
- hepatitis C virus; core protein; hepatocarcinogenesis; Rb pathway; C VIRUS CORE; RAT EMBRYO FIBROBLASTS; CELL-CYCLE CONTROL; RETINOBLASTOMA PROTEIN; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; MAMMALIAN-CELLS; APOPTOSIS; SUPPRESSION; CANCER
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/19685
- DOI
- 10.1016/S0167-4889(00)00137-3
- ISSN
- 0167-4889
- Article Type
- Article
- Citation
- BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, vol. 1538, no. 1, page. 59 - 66, 2001-02-05
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.